AlzeCure Pharma AB OMXSTO:ALZCUR:RIGHTS ISSUE SUBSCRIBED TO ABOUT 329%
RE Reuters AlzeCure Pharma Rights Issue Oversubscribed 7/2/2026, 02:09 PM GMT+8 Reuters AL ALZCUR AlzeCure Pharma AB OMXSTO:ALZCUR: AlzeCure Pharma AB OMXSTO:ALZCUR:RIGHTS ISSUE SUBSCRIBED TO ABOUT 329% Market News MFN by Modular Finance BioStock publishes the Q2 2026 edition of State of Nordic Biopharma MFN by Modular Finance Final outcome of AlzeCureās rights issue Reuters AlzeCure signs out-licensing, collaboration deal worth over $2.2 billion Reuters Alzecure Pharma Enters Out-Licensing, Collaboration Deal With Quantumcell Aps